{"type":"video","version":"1.0","html":"<iframe src=\"https://www.loom.com/embed/1868fe9f1812435bbc3247f6501a9bd9\" frameborder=\"0\" width=\"1216\" height=\"912\" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>","height":912,"width":1216,"provider_name":"Loom","provider_url":"https://www.loom.com","thumbnail_height":912,"thumbnail_width":1216,"thumbnail_url":"https://cdn.loom.com/sessions/thumbnails/1868fe9f1812435bbc3247f6501a9bd9-f0a39e775e27fe33.gif","duration":245.035,"title":"Streamlining Pre-Clinical Safety Reviews with AI Technology","description":"In this video, I walk you through our innovative system that streamlines the pre-clinical safety review process required by the FDA before drug trials. We can significantly reduce the time and cost associated with manual reviews, which typically range from $15,000 to $25,000 and take three to four weeks. Our AI-driven platform extracts critical data, assesses compliance against 95 rules derived from ICH and FDA guidelines, and generates comprehensive reports. I also highlight the importance of addressing any flagged issues to avoid clinical holds, and I encourage you to upload any additional documents needed for a complete assessment. Let's ensure we meet all requirements efficiently and effectively."}